This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to provide the antiviral medication zanamivir. The $263,537.64 contract has a completion date of December 6, 2017 and does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products to U.S. government agencies, including influenza vaccines, COVID-19 treatments, and other antiviral medications, through various federal contracts and grants. The company also serves as a subcontractor supporting distribution and logistics for a $280 million Department of Defense contract for COVID-19 monoclonal antibody therapeutics.